JK
Insider selling
James Kihara sold $114K of ACAD stock
James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals Inc (ACAD), sold 5,401 shares of ACAD stock worth $114K, per an SEC Form 4 filed May 27, 2026.
It was an open-market sale.
The trade happened on May 26, 2026, 1 day before it was made public.
ACAD has moved -3.2% since the trade date, from $21.26 to $20.59 (Oct 30, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 27, 2026
- Filing delay
- 1 day
- Price since
- -3.2%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4
More ACAD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.